These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 19912056

  • 1. Novel diphenyl esters of peptidyl alpha-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin.
    Pietrusewicz E, Sieńczyk M, Oleksyszyn J.
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1229-36. PubMed ID: 19912056
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Utilization of biotinylated diphenyl phosphonates for disclosure of serine proteases.
    Hawthorne S, Hamilton R, Walker BJ, Walker B.
    Anal Biochem; 2004 Mar 15; 326(2):273-5. PubMed ID: 15003568
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
    Abuelyaman AS, Jackson DS, Hudig D, Woodard SL, Powers JC.
    Arch Biochem Biophys; 1997 Aug 15; 344(2):271-80. PubMed ID: 9264539
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J, Mucha A, Cierpicki T, Kafarski P.
    J Med Chem; 2003 Jun 19; 46(13):2641-55. PubMed ID: 12801228
    [Abstract] [Full Text] [Related]

  • 11. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
    Iijima K, Katada J, Yasuda E, Uno I, Hayashi Y.
    J Med Chem; 1999 Jan 28; 42(2):312-23. PubMed ID: 9925737
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D, Fittkau S.
    Biomed Biochim Acta; 1985 Jan 28; 44(7-8):1089-94. PubMed ID: 3910035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4.
    O'Sullivan DB, O'Connell TP, Mahon MM, Koenig A, Milne JJ, Fitzpatrick TB, Malthouse JP.
    Biochemistry; 1999 May 11; 38(19):6187-94. PubMed ID: 10320347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.